Christopher is the CEO of Harmonic Bionics, and has over 20 years of successful medical device experience in both large strategic healthcare companies and successful startup companies. A lot of Christopher’s time has been spent specifically with robotic companies seeking high growth by increasing the adoption of technology that challenges the status quo.​

For Harmonic he is leading the development of a bilateral, upper-extremity exoskeleton dynamically designed to provide unique value in three areas of practice: neuroscience and movement science research, movement disorder assessment, and rehabilitation.​

Prior to his most recent position at Medtronic, he was CEO of Mazor Robotics, Inc. and Chief Commercial Officer of Mazor Robotics Ltd., companies that were acquired by Medtronic in December 2018.

He is a West Point graduate with a master’s degree in Business Administration, as well as Healthcare Administration. ​

​